S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
NYSE:GMED

Globus Medical - GMED Stock Forecast, Price & News

$72.28
-2.67 (-3.56%)
(As of 12/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$72.08
$74.36
50-Day Range
$58.06
$75.50
52-Week Range
$52.60
$81.78
Volume
530,177 shs
Average Volume
670,296 shs
Market Capitalization
$7.22 billion
P/E Ratio
47.87
Dividend Yield
N/A
Price Target
$75.08

Globus Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
3.9% Upside
$75.08 Price Target
Short Interest
Bearish
7.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.93
Upright™ Environmental Score
News Sentiment
-0.04mentions of Globus Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$562,500 Sold Last Quarter
Proj. Earnings Growth
15.27%
From $2.03 to $2.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

458th out of 1,033 stocks

Surgical & Medical Instruments Industry

46th out of 104 stocks

GMED stock logo

About Globus Medical (NYSE:GMED) Stock

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Stock News Headlines

Globus Medical (NYSE:GMED) Downgraded to "Hold" at StockNews.com
Company News for Nov 10, 2022
Needham Reaffirms Their Buy Rating on Globus Medical (GMED)
BTIG Keeps Their Buy Rating on Globus Medical (GMED)
Globus Medical Reports Third Quarter 2022 Results
Globus Medical (GMED) Q3 Earnings Lag Estimates
Globus Medical's Earnings Outlook
Globus Medical Inc - Ordinary Shares - Class A
Could Globus Medical Be the Best Healthcare Stock?
First Week of GMED October 21st Options Trading
Analyst Ratings for Globus Medical
See More Headlines
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Company Calendar

Last Earnings
11/04/2021
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/16/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
37957720
Employees
2,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$75.08
High Stock Price Forecast
$91.00
Low Stock Price Forecast
$68.00
Forecasted Upside/Downside
+3.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$149.19 million
Pretax Margin
20.11%

Debt

Sales & Book Value

Annual Sales
$958.10 million
Cash Flow
$2.70 per share
Book Value
$17.15 per share

Miscellaneous

Free Float
75,471,000
Market Cap
$7.22 billion
Optionable
Optionable
Beta
1.05

Key Executives

  • Mr. David C. Paul (Age 55)
    Co-Founder & Exec. Chairman
    Comp: $23.57k
  • Mr. Daniel T. ScavillaMr. Daniel T. Scavilla (Age 57)
    Pres, CEO & Director
    Comp: $965.17k
  • Mr. Keith W. PfeilMr. Keith W. Pfeil (Age 43)
    Sr. VP & CFO
    Comp: $623.41k
  • Ms. Kelly G. Huller Esq. (Age 50)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $543.02k
  • Mr. Brian J. Kearns (Age 55)
    Sr. VP of Bus. Devel. & Investor Relations
  • Mr. A. Brett Murphy (Age 57)
    Exec. VP of International Sales
  • Mr. Steven M. Payne (Age 51)
    VP & Controller
  • Mr. Mike Reeder
    Exec. Officer
  • Mr. Richard Holifield
    Exec. Officer
  • Mr. John Dowling
    Exec. Officer













GMED Stock - Frequently Asked Questions

Should I buy or sell Globus Medical stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GMED shares.
View GMED analyst ratings
or view top-rated stocks.

What is Globus Medical's stock price forecast for 2023?

10 brokerages have issued 12 month price targets for Globus Medical's stock. Their GMED share price forecasts range from $68.00 to $91.00. On average, they anticipate the company's stock price to reach $75.08 in the next year. This suggests a possible upside of 3.9% from the stock's current price.
View analysts price targets for GMED
or view top-rated stocks among Wall Street analysts.

How have GMED shares performed in 2022?

Globus Medical's stock was trading at $72.20 at the start of the year. Since then, GMED stock has increased by 0.1% and is now trading at $72.28.
View the best growth stocks for 2022 here
.

Are investors shorting Globus Medical?

Globus Medical saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,380,000 shares, an increase of 9.3% from the October 15th total of 4,920,000 shares. Based on an average daily volume of 574,900 shares, the days-to-cover ratio is presently 9.4 days.
View Globus Medical's Short Interest
.

When is Globus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our GMED earnings forecast
.

How were Globus Medical's earnings last quarter?

Globus Medical, Inc. (NYSE:GMED) announced its quarterly earnings results on Thursday, November, 4th. The medical device company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.05. The medical device company earned $229.72 million during the quarter, compared to analysts' expectations of $228.28 million. Globus Medical had a net margin of 15.55% and a trailing twelve-month return on equity of 11.59%. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 earnings per share.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical updated its FY22 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $2.03-$2.10 for the period, compared to the consensus EPS estimate of $2.10. The company issued revenue guidance of $1.025 billion, compared to the consensus revenue estimate of $1.03 billion.

What is David Demski's approval rating as Globus Medical's CEO?

47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Globus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA).

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

Who are Globus Medical's major shareholders?

Globus Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.29%), Vanguard Group Inc. (7.23%), Kayne Anderson Rudnick Investment Management LLC (4.58%), State Street Corp (2.20%), AXA S.A. (1.51%) and Geneva Capital Management LLC (1.41%). Insiders that own company stock include Daniel T Scavilla, Daniel T Scavilla, David D Davidar, David M Demski, James R Tobin, James R Tobin, Keith W Pfeil, Keith W Pfeil, Kelly Huller and Robert Andrew Douglas.
View institutional ownership trends
.

How do I buy shares of Globus Medical?

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Globus Medical's stock price today?

One share of GMED stock can currently be purchased for approximately $72.28.

How much money does Globus Medical make?

Globus Medical (NYSE:GMED) has a market capitalization of $7.22 billion and generates $958.10 million in revenue each year. The medical device company earns $149.19 million in net income (profit) each year or $1.51 on an earnings per share basis.

How many employees does Globus Medical have?

The company employs 2,400 workers across the globe.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The official website for the company is www.globusmedical.com. The medical device company can be reached via phone at (610) 930-1800, via email at investors@globusmedical.com, or via fax at 610-930-2042.

This page (NYSE:GMED) was last updated on 12/6/2022 by MarketBeat.com Staff